SEC Form 4 · accession 0000921895-16-004414
Enveric Biosciences, Inc. · ENVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dhruwa N Rai
Director
Period of report
May 10, 2016
Accepted (ET)
May 10, 2016 · 5:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 500,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (Right to Buy)F1 | $7.00 | May 10, 2016 | A | 500,000 | A | May 10, 2017 | May 10, 2022 | Common Stock | 500,000 | 500,000 | D |
| Restricted Stock UnitF2,F3 | — | May 10, 2016 | A | 500,000 | A | — | — | Common Stock | 500,000 | 500,000 | D |
Explanation of responses
- F1The Option vests as follows: (a) as to 166,667 shares of common stock of the Issuer ("Stock), on May 10, 2017, (b) as to a further 166,667 shares of Stock, on May 10, 2018, and (c) as to the remaining 166,666 shares of Stock, on May 10, 2019.
- F2Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock.
- F3These Restricted Stock Units are scheduled to vest as follows: (a) as to 166,667 Shares, onMay 10, 2017, (b) as to a further 166,667 Shares, on May 10, 2018, and (c) as to the remaining 166,666 Shares, onMay 10, 2019.